Redirecting to https://www.tradingview.com/news/reuters.com,2026:newsml_TUABJGWS6:0-phase-iii-find-ckd-results-show-bayer-s-kerendia-finerenone-improved-egfr-slope-and-reduced-risk-of-a-composite-kidney-cardiovascular-outcome-in-adults-with-non-diabetic-chronic-kidney-disease/